XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue:    
Option Revenue $ 0 $ 726,291
Research and development 206,024 1,829,062
General and administrative 719,869 987,248
Depreciation and amortization 0 72,589
Operating loss (925,893) (2,162,608)
Interest income (expense), net (846) 108
Other income (expense), net 467 2,106
Net loss $ (926,272) $ (2,160,394)
Basic and diluted loss per share $ (0.12) $ (0.31)
Weighted average shares outstanding - Basic and diluted 7,597,769 6,982,909